Density Gradient Separation of Pharmaceutical Polymorphs

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The pharmaceutical industry faces challenges in accurately identifying and controlling polymorphic forms of active pharmaceutical ingredients (APIs) due to their varying bioavailability, stability, and potential conversion during production and storage, which can lead to inconsistent product quality and safety issues.

Innovation Solution

A method utilizing a density gradient system to mechanically separate polymorphic forms of APIs based on their densities, allowing for the enumeration and characterization of multiple forms present in pharmaceutical preparations, including solvates and salts, using a fluid density gradient in a container with particles immersed, observing stable positions, and determining respective densities for separation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods (XRD, DSC, Raman) are used to identify polymorphic forms, then characterization information can be obtained, but the methods provide signals from all components making it difficult to detect minor polymorphic forms and require prior knowledge of spectral signals

Engineering Contradiction:

Improvedetection of polymorphic formsVSAvoiddetection of minor polymorphic forms

Core Design Contradiction:

Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the complex mixture signal into individual polymorphic form signals by separating particles based on density before analysis. Each polymorphic form settles at a different position in the density gradient column, allowing individual characterization without interference from other forms. This segmentation enables detection of minor forms that would be masked in bulk analysis.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent extracts individual polymorphic forms from the mixture by density-based separation. Each form is physically removed from the mixture and isolated at its specific density level in the gradient column, enabling independent analysis without the confounding presence of other polymorphic forms or excipients.

Inventive Principle:

Principle #2Taking out (Extraction)

2Adaptability or versatility

If multiple different treatments are applied to samples (as in U.S. Pat. No. 6,965,832), then polymorphic forms can be formed, but physical separation is not achieved and distinct treatments are required for each sample

Engineering Contradiction:

Improveformation of polymorphic formsVSAvoidmultiple different treatments

Core Design Contradiction:

Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent replaces complex chemical and thermal treatment systems with a simple mechanical density gradient separation system. Instead of applying multiple different chemical/solvent treatments to form and separate polymorphs, the system uses a passive density gradient column where particles automatically separate based on their inherent density differences, eliminating the need for multiple treatment protocols.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If density gradient separation is used (as in U.S. Pat. No. 6,709,871), then separation based on density is achieved, but the system is designed for aqueous solvents and low densities appropriate for cell separation, not pharmaceutical crystalline materials

Engineering Contradiction:

Improveseparation based on densityVSAvoidapplication to pharmaceutical materials

Core Design Contradiction:

Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent modifies the density gradient system by changing the solvent parameters from aqueous to organic solvents with higher densities suitable for pharmaceutical crystalline materials. The gradient range is adjusted to match the density range of pharmaceutical polymorphs (1.3-2.0 g/cm³), and the system is adapted to handle non-aqueous solvents, making it versatile for pharmaceutical applications while maintaining precise density-based separation.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a simple, inexpensive, and immediate visual separation of polymorphic forms, enabling reliable identification and monitoring of API forms, ensuring consistent product quality and safety throughout the pharmaceutical supply chain.

Implementation Method 1

providing a fluid having a density gradient in a container situated in a gravitational field and having immersed therein a specimen comprising at least two particles of the API in a pharmaceutical preparation, the density gradient having a greater density at a lower extremity of the container in the gravitational field and a lesser density at a location above the lower extremity in the gravitational field

Methodology Applied

Scientific EffectDensity gradient: Density Gradient